Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany].

Benesova K, Lorenz HM, Lion V, Voigt A, Krause A, Sander O, Schneider M, Feuchtenberger M, Nigg A, Leipe J, Briem S, Tiessen E, Haas F, Rihl M, Meyer-Olson D, Baraliakos X, Braun J, Schwarting A, Dreher M, Witte T, Assmann G, Hoeper K, Schmidt RE, Bartz-Bazzanella P, Gaubitz M, Specker C.

Z Rheumatol. 2019 Oct;78(8):722-742. doi: 10.1007/s00393-019-0683-y. Review. German.

PMID:
31468170
2.

Power-Doppler perfusion phenotype in RA patients is dependent on anti-citrullinated peptide antibody status, not on rheumatoid factor.

Gadeholt O, Feuchtenberger M, Wech T, Schwaneck EC.

Rheumatol Int. 2019 Jun;39(6):1019-1025. doi: 10.1007/s00296-019-04256-1. Epub 2019 Feb 26.

PMID:
30806731
3.

Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.

Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J.

J Rheumatol. 2019 May;46(5):460-466. doi: 10.3899/jrheum.180028. Epub 2018 Dec 1.

PMID:
30504510
4.

Simple screening tools predict death and cardiovascular events in patients with rheumatic disease.

Breunig M, Kleinert S, Lehmann S, Kneitz C, Feuchtenberger M, Tony HP, Angermann CE, Ertl G, Störk S.

Scand J Rheumatol. 2018 Mar;47(2):102-109. doi: 10.1080/03009742.2017.1337924. Epub 2017 Aug 16.

PMID:
28812405
5.

Rate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions.

Feuchtenberger M, Nigg AP, Kraus MR, Schäfer A.

Clin Med Insights Arthritis Musculoskelet Disord. 2016 Oct 2;9:181-187. eCollection 2016.

6.

Hepatitis B Serology in Patients with Rheumatic Diseases.

Feuchtenberger M, Schäfer A, Philipp Nigg A, Rupert Kraus M.

Open Rheumatol J. 2016 Aug 31;10:39-48. eCollection 2016.

7.

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.

Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Rech J, Schett G.

Ann Rheum Dis. 2017 Feb;76(2):399-407. doi: 10.1136/annrheumdis-2016-209297. Epub 2016 Jun 20.

PMID:
27323772
8.

[E-learning program from the German Society of Rheumatology].

Feuchtenberger M, Riemekasten G.

Z Rheumatol. 2016 Jun;75(5):440-1. doi: 10.1007/s00393-016-0095-1. German. No abstract available.

PMID:
27240843
9.

[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)].

Riemekasten G, Aringer M, Baerwald CG, Meyer-Bahlburg A, Bergner R, Feuchtenberger M, Gebhardt C, Hellmich B, Keyßer G, Lorenz HM, Kneitz C, Witte T, Müller-Ladner U, Schneider M, Braun J, Rautenstrauch J, Specker C, Schulze-Koops H.

Z Rheumatol. 2016 Jun;75(5):493-501. doi: 10.1007/s00393-016-0079-1. German.

PMID:
27193335
10.

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.

Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G.

Ann Rheum Dis. 2016 Sep;75(9):1637-44. doi: 10.1136/annrheumdis-2015-207900. Epub 2015 Oct 19.

11.

Long-term repopulation of peripheral B-cell subsets after single and repeated rituximab infusions in patients with rheumatoid arthritis.

Roll P, Mahmood Z, Muhammad K, Feuchtenberger M, Dörner T, Tony HP.

Clin Exp Rheumatol. 2015 May-Jun;33(3):347-53. Epub 2015 Apr 16.

PMID:
25897997
12.

The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.

Feuchtenberger M, Kleinert S, Scharbatke EC, Gnann H, Behrens F, Wittig BM, Greger G, Tony HP.

Clin Exp Rheumatol. 2015 May-Jun;33(3):321-9. Epub 2015 Apr 14.

PMID:
25897681
13.

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.

Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nuesslein H, Alten R, Demary W, Henes J, Schett G, Rech J.

Ann Rheum Dis. 2016 Jan;75(1):45-51. doi: 10.1136/annrheumdis-2014-206439. Epub 2015 Feb 6.

PMID:
25660991
14.

Renal perfusion in scleroderma patients assessed by microbubble-based contrast-enhanced ultrasound.

Kleinert S, Roll P, Baumgaertner C, Himsel A, Mueller A, Fleck M, Feuchtenberger M, Jenett M, Tony HP.

Open Rheumatol J. 2012;6:50-3. doi: 10.2174/1874312901206010050. Epub 2012 May 30.

15.

Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.

Kleinert S, Tony HP, Krueger K, Detert J, Mielke F, Rockwitz K, Schwenke R, Burmester GR, Diel R, Feuchtenberger M, Kneitz C.

Ann Rheum Dis. 2012 Nov;71(11):1791-5. doi: 10.1136/annrheumdis-2011-200941. Epub 2012 May 14.

PMID:
22586160
16.

Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study.

Kleinert S, Tony HP, Krause A, Feuchtenberger M, Wassenberg S, Richter C, Röther E, Spieler W, Gnann H, Wittig BM.

Rheumatol Int. 2012 Sep;32(9):2759-67. doi: 10.1007/s00296-011-2033-5. Epub 2011 Aug 6.

17.

Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study.

Feuchtenberger M, Kleinert S, Schwab S, Roll P, Scharbatke EC, Ostermeier E, Voll RE, Schäfer A, Tony HP.

Rheumatol Int. 2012 Jun;32(6):1533-9. doi: 10.1007/s00296-011-1808-z. Epub 2011 Feb 15.

PMID:
21327432
18.

Expression of K2P5.1 potassium channels on CD4+ T lymphocytes correlates with disease activity in rheumatoid arthritis patients.

Bittner S, Bobak N, Feuchtenberger M, Herrmann AM, Göbel K, Kinne RW, Hansen AJ, Budde T, Kleinschnitz C, Frey O, Tony HP, Wiendl H, Meuth SG.

Arthritis Res Ther. 2011 Feb 11;13(1):R21. doi: 10.1186/ar3245.

19.

[Vaccinations in rheumatology].

Feuchtenberger M, Voll RE, Kneitz C.

Z Rheumatol. 2010 Nov;69(9):803-12. doi: 10.1007/s00393-010-0707-0. German.

PMID:
21063829
20.

[Systemic lupus erythematosus. A problem based approach].

Kleinert S, Feuchtenberger M, Tony HP.

Internist (Berl). 2010 Aug;51(8):1013-26; quiz 1027-8. doi: 10.1007/s00108-010-2682-6. Review. German.

PMID:
20628717
21.

Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases.

Kleinert S, Kurzai O, Elias J, Marten K, Engelke C, Feuchtenberger M, Sandstede J, Frosch M, Tony HP, Kneitz C.

Ann Rheum Dis. 2010 Apr;69(4):782-4. doi: 10.1136/ard.2009.113829. Epub 2010 Feb 25. No abstract available.

PMID:
20185504
22.

Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case Report.

Feuchtenberger M, Kneitz C, Roll P, Kleinert S, Tony HP.

Open Rheumatol J. 2009 Feb 9;3:9-13. doi: 10.2174/1874312900903010009.

23.

Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.

Feuchtenberger M, Müller S, Roll P, Waschbisch A, Schäfer A, Kneitz C, Wiendl H, Tony HP.

Open Rheumatol J. 2008;2:81-8. doi: 10.2174/1874312900802010081. Epub 2008 Dec 3.

24.

Psoriatic arthritis: therapeutic principles.

Feuchtenberger M, Kleinert S, Tony HP, Kneitz C.

Clin Dermatol. 2008 Sep-Oct;26(5):460-3. doi: 10.1016/j.clindermatol.2007.11.005. Review.

PMID:
18755364
25.

Psoriatic arthritis: clinical spectrum and diagnostic procedures.

Kleinert S, Feuchtenberger M, Kneitz C, Tony HP.

Clin Dermatol. 2007 Nov-Dec;25(6):519-23. Review.

PMID:
18021887
26.

[Treatment of rheumatoid arthritis (RA) with anticytokines].

Feuchtenberger M, Kneitz C, Tony HP.

MMW Fortschr Med. 2006 Oct 19;148(42):44-5, 47. German.

PMID:
17621799
27.

[Cytokines].

Feuchtenberger M, Kneitz C, Tony HP.

Z Rheumatol. 2007 Jul;66(4):297-8, 300-3. Review. German.

PMID:
17522870
28.

Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development.

Ströbel P, Marino M, Feuchtenberger M, Rouzière AS, Tony HP, Wulbrand U, Förster R, Zettl A, Lee Harris N, Kreipe H, Laeng RH, Müller-Hermelink HK, Marx A.

J Pathol. 2005 Sep;207(1):72-82.

PMID:
15965907
29.

Semiquantitative and qualitative assessment of B-lymphocyte V H repertoire by a fluorescent multiplex PCR.

Feuchtenberger M, Tony HP, Rouzière AS, Jacobi A, Dörner T, Kneitz C, Starostik P.

J Immunol Methods. 2003 May 1;276(1-2):121-7.

PMID:
12738364

Supplemental Content

Loading ...
Support Center